Dwight H. Egan
Chief Executive Officer at Co-Diagnostics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Co-Diagnostics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Co-Diagnostics Inc. May 28, 202581.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 23, 2026 | Co-Diagnostics Inc. | Grant or award | +4,584 | — | — |
| May 23, 2026 | Co-Diagnostics Inc. | Sold back to the company | −1,633 | $5.07 | $8,279 |
| Nov 23, 2025 | Co-Diagnostics Inc. | Grant or award | +163,333 | — | — |
| Nov 23, 2025 | Co-Diagnostics Inc. | Sold back to the company | −49,575 | $0.35 | $17,351 |
| May 23, 2025 | Co-Diagnostics Inc. | Grant or award | +163,334 | — | — |
| May 23, 2025 | Co-Diagnostics Inc. | Sold back to the company | −51,697 | $0.24 | $12,407 |
| Nov 23, 2024 | Co-Diagnostics Inc. | Grant or award | +163,333 | — | — |
| Nov 23, 2024 | Co-Diagnostics Inc. | Sold back to the company | −49,689 | $1.01 | $50,186 |
| May 23, 2024 | Co-Diagnostics Inc. | Grant or award | +138,333 | — | — |
| May 23, 2024 | Co-Diagnostics Inc. | Sold back to the company | −42,008 | $1.09 | $45,789 |
| Nov 23, 2023 | Co-Diagnostics Inc. | Grant or award | +150,834 | — | — |
| Nov 23, 2023 | Co-Diagnostics Inc. | Sold back to the company | −46,047 | $1.26 | $58,019 |
| May 23, 2023 | Co-Diagnostics Inc. | Grant or award | +105,000 | — | — |
| May 23, 2023 | Co-Diagnostics Inc. | Sold back to the company | −32,103 | $1.32 | $42,376 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.